Kosta Grozos

Kosta Grozos (born 10 August 2000) is an Australian professional footballer who plays as a midfielder for Western Sydney Wanderers.[1] He is of Greek descent.[2]

Kosta Grozos
Personal information
Full name Kostandinos Grozos
Date of birth (2000-08-10) 10 August 2000
Place of birth Kingsgrove, Australia
Playing position(s) Midfielder
Club information
Current team
Western Sydney Wanderers
Number 23
Youth career
Sutherland Sharks
2016– Western Sydney Wanderers
Senior career*
Years Team Apps (Gls)
2016– Western Sydney Wanderers NPL 24 (14)
2018– Western Sydney Wanderers 1 (0)
National team
2017– Australia U-20 2 (0)
* Senior club appearances and goals counted for the domestic league only and correct as of 26 September 2019
‡ National team caps and goals correct as of 6 October 2018

Career

Western Sydney Wanderers

In 2017, Grozos was awarded the Wanderer's NPL Player of the Year having scored 11 goals in 13 games for the Youth team in their NPL NSW 2 campaign.[3]

Grozos was part of the 2017-18 Y-League championship winning Western Sydney Wanderers Youth team. He played the full game as they beat Melbourne City Youth 3–1 in the 2018 Y-League Grand Final on 3 February 2018.[4]

On 7 August 2018, Grozos made his professional debut in a Round of 16 FFA Cup clash with Hellenic Athletic, starting the game before being withdrawn for Nick Fitzgerald in the 26th minute due to an injury, the Wanderers going on to win the match 4–3.[5] He made his second appearance for Western Sydney in their 3-0 FFA Cup semi-final loss to Sydney FC on 8 October 2018, with Grozos playing the full game.[6] Two days later, he was awarded with a two-year professional contract with the Wanderers.[7]

International career

He is a youth international for the Australia U-20s.

Honours

Club

Western Sydney Wanderers

gollark: Maybe contact tracing would have been somewhat better with 2029 technology; there seems to be a lot of work on position/thing sensing using mobile devices' radios and such now, and by then it would probably have matured. (Yes, this is overly specific, but things)
gollark: And remote work and associated tooling would probably be further along.
gollark: We might have had somewhat better medical technology to combat it with initially, I guess.
gollark: I think the effectiveness numbers are better for the Pfizer one.
gollark: We get home lateral flow tests here.

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.